Alligator Bioscience Calls AGM and Proposes No Dividend Amid Continued Losses

Alligator Bioscience AB ( (SE:ATORX) ) just unveiled an announcement.

Alligator Bioscience AB has called its annual general meeting for 6 May 2026 at Medicon Village in Lund, Sweden, setting out the formal requirements for shareholder participation, including share registration and notice procedures. The agenda covers standard corporate governance items such as approval of the annual and consolidated reports, discharge of liability for the board and CEO, remuneration matters, board and auditor elections, and an authorization regarding share issues.

The nomination committee proposes lawyer Ola Grahn as chairman of the meeting, underscoring the company’s focus on orderly governance and compliance with Swedish corporate practice. The board also proposes that no dividend be paid for the year and that the accumulated loss of SEK 83.3 million be carried forward, which signals the company’s continued prioritization of capital preservation and reinvestment over shareholder payouts, a common stance for R&D-driven biotech firms.

The most recent analyst rating on (SE:ATORX) stock is a Sell with a SEK0.16 price target. To see the full list of analyst forecasts on Alligator Bioscience AB stock, see the SE:ATORX Stock Forecast page.

More about Alligator Bioscience AB

Alligator Bioscience AB is a Swedish biotechnology company based in Lund, focusing on the development of immuno-oncology therapies. The company operates within the life sciences sector, targeting innovative cancer treatments, and is listed on the Swedish market with a shareholder base that includes institutional and private investors.

YTD Price Performance: -49.70%

Average Trading Volume: 5,291,805

Technical Sentiment Signal: Strong Sell

Current Market Cap: SEK90.65M

See more data about ATORX stock on TipRanks’ Stock Analysis page.